Protalix BioTherapeutics (PLX) Price to FCF (2018 - 2026)
Protalix BioTherapeutics' (PLX) Price to FCF came in at 24.48 for Q2 2026, up 82.0% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Price to FCF (2018 - 2026) Analysis & Trends
For FY2024, Protalix BioTherapeutics' Price to FCF stood at 19.29.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 204.37 Mn | 52.98 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.48 |
| Mar 31, 2026 | 13.45 |
| Dec 31, 2024 | 19.29 |
| Sep 30, 2024 | 10.47 |
| Mar 31, 2024 | 21.14 |
| Sep 30, 2018 | 8.22 |
API Access
Protalix BioTherapeutics Price to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-fcf", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();